Viswanath Kasisomayajula Ph D - MA Middlesex, Cambridge 02139

Viswanath Kasisomayajula Ph D entered the industry of Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Viswanath Kasisomayajula by calling (617) 354-2333 during business hours. You can also write to the business’ Single Location at 165 Pleasant St Apartment 314, Cambridge, Massachusetts MA 02139. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Viswanath Kasisomayajula Ph D
Representative: Viswanath Kasisomayajula
Place of Business: 165 Pleasant St Apartment 314, Cambridge, MA 02139
Contact Number: (617) 354-2333
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2004
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Viswanath Kasisomayajula Ph D is a company operating from Middlesex, Massachusetts providing professional Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.

With a current employee count of 1 to 4, Viswanath Kasisomayajula Ph D has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Viswanath Kasisomayajula at (617) 354-2333 for related queries, or to locate its Single Location using the coordinates 42.359392,-71.113821.

The Single Location can also be found at the street address 165 Pleasant St Apartment 314 in Cambridge, Massachusetts 02139 and can be engaged online through the company website at , the company Twitter , and Facebook page .